EV
Eric Venker (President & Immunovant CEO) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales, 1 filed past the two-business-day deadline), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $7.3M of ROIV (200,000 sh × $36.62, as filed), executed Sep 30. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
17
0 buys · 17 sells · 1 late
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$87.9M
shares × price, as filed
Last traded
Nov 3
Filed Nov 5
Median ADV $222.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $181.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
17 filings
Sector per market data · by filing · past 12 months
Most traded names
ROIVRecent filings
ROIVSALE
Roivant Sciences Ltd.
View filing →
$1.1M100,000 sh × $11.45
Exec Jun 20 2025
Filed Jun 24 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $11.2M
1,000,000 sh across 2 lots
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $1.1M
100,000 sh × $10.95
Exec May 20 2025
Filed May 22 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $1.0M
100,000 sh × $10.22
Exec Apr 21 2025
Filed Apr 22 2025 · 5:30 PM ET